2027 ICD-10-CM Diagnosis Code G62.2Polyneuropathy due to other toxic agents
ICD-10-CM Codes›G00–G99›G60-G65›G62
- Billable — Valid for Submission
- Chronic Condition
G62.2 is a billable ICD-10-CM diagnosis code for polyneuropathy due to other toxic agents. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 73 through 74. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Drug induced or toxic related condition and Polyneuropathies.
G62.2 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 75 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the PACE (CMS-HCC V22) category 75, ESRD (V21) category 75, ESRD (V24) category 75, and RxHCC Part D (V08) category 158 for payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
G62.2 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Inflammatory and toxic neuropathy
- Insect venom-induced neurotoxicity
- Lead neuropathy
- Lead-induced peripheral neuropathy
- Local toxic nerve damage
- Neuropathy caused by chemical substance
- Neuropathy caused by heavy metal
- Neuropathy caused by organic substance
- Neurotoxicity
- Neurotoxicity caused by snake venom
- Peripheral neuropathy caused by ciguatoxin
- Peripheral neuropathy caused by toxin
- Peripheral neuropathy of upper limb caused by toxin
- Reptile venom-induced neurotoxicity
- Toxic polyneuropathy
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to G62.2: its own notes plus those printed at block G60-G65 and Chapter 6. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Code First
The underlying condition named in the note is sequenced before this code.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Jamaica (ginger) G62.2
peripheral (nerve) See Also: Polyneuropathy; G62.9
arsenic G62.2
lead G62.2
toxic agent NEC G62.2
toxic NEC G62.2
Polyneuropathy (peripheral) G62.9
arsenical G62.2
arsenic G62.2
lead G62.2
toxic agent NEC G62.2
triorthocresyl phosphate G62.2
lead G62.2
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Peripheral Nerve Disorders
Nerves are like wires that carry messages back and forth between your brain and your body. Your peripheral nerves branch off from your brain and spinal cord and connect to all parts of your body, including your muscles and organs.
The full article covers:
- What are peripheral nerves?
- What are peripheral nerve disorders?
- What causes peripheral nerve disorders?
- What are the symptoms of peripheral nerve disorders?
- How are peripheral nerve disorders diagnosed?
- What are the treatments for peripheral nerve disorders?
- Can peripheral nerve disorders be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert G62.2 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About G62.2Overview
What is the ICD-10 code for polyneuropathy due to other toxic agents?
The ICD-10-CM code for polyneuropathy due to other toxic agents is G62.2 (sometimes written as G622). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is G62.2 (Other and unspecified polyneuropathies) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report polyneuropathy due to other toxic agents on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does G62.2 group to?
When polyneuropathy due to other toxic agents is the principal diagnosis on an inpatient stay, it groups to MS-DRG 74, 73, with relative weights from 1.0172 to 1.5773 depending on complications. Higher weights mean higher Medicare reimbursement.
Can G62.2 be reported with M79.2?
Not as a rule. The Excludes1 note at block G60-G65, which applies to G62.2, lists "neuralgia NOS (M79.2)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
What is coded first with G62.2?
The Code First note reads: (T51-T65) to identify toxic agent. When one of these applies, it is sequenced before G62.2.
Does G62.2 risk-adjust for Medicare Advantage payment?
Not for Medicare Advantage. G62.2 mapped to HCC 75 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the PACE (CMS-HCC V22) category 75 (Myasthenia Gravis/Myoneural Disorders and Guillain-Barre Syndrome/Inflammatory and Toxic Neuropathy), ESRD (V21) category 75 (Polyneuropathy), ESRD (V24) category 75 (Myasthenia Gravis/Myoneural Disorders and Guillain-Barre Syndrome/Inflammatory and Toxic Neuropathy), and RxHCC Part D (V08) category 158 (Inflammatory and Toxic Neuropathy).